Results 111 to 120 of about 1,458 (206)

Olopatadine in the management of allergic conjunctivitis

open access: yesSouth African General Practitioner, 2021
openaire   +1 more source

Nrp1 Signaling Reprograms Glutathione Metabolism to Drive Mitochondrial Dysfunction in Severe Asthma. [PDF]

open access: yesAntioxidants (Basel)
Huang J   +14 more
europepmc   +1 more source

Olopatadine vs. Rupatadine for Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials. [PDF]

open access: yesCureus
Rehman A   +10 more
europepmc   +1 more source

Internal validity gaps in repurposing olopatadine ophthalmic solution for intranasal use: A Regulatory and scientific feasibility appraisal for Thailand

open access: yes
Background: Allergic rhinitis is a prevalent condition that often requires local treatment to minimize systemic side effects. While intranasal antihistamines are effective, access in some settings is limited. Olopatadine hydrochloride, currently approved
Rattanamanee, Kwanchai   +10 more
core  

Eosinophilic esophagitis is associated with increased risk of allergic conjunctivitis: a multicenter cohort study. [PDF]

open access: yesJ Ophthalmic Inflamm Infect
Lishinsky-Fischer N   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy